The simulator also controls the strength of exhalations, meaning that the team could investigate how this and the size of nasal airways affects aerosol cloud dispersion. During their experiments, ...

Kenox Pharma partners with Lactiga for development of novel mucosal-targeted Secretory IgA therapies for immunodeficient patients: Princeton, New Jersey Wednesday, March 12, 2025, ...

Kenox Pharmaceuticals Inc. and Lactiga US, Inc. are pleased to announce a strategic collaboration to advance the development ...